• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

斯洛文尼亚的莱伯遗传性视神经病变:从患者角度看生活质量和成本。

Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective.

机构信息

Eye Hospital, University Medical Centre Ljubljana, Ljubljana, Slovenia.

CEEOR s.r.o., Prague, Czechia.

出版信息

Orphanet J Rare Dis. 2024 Aug 30;19(1):318. doi: 10.1186/s13023-024-03329-0.

DOI:10.1186/s13023-024-03329-0
PMID:39215330
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11365147/
Abstract

INTRODUCTION

Leber hereditary optic neuropathy (LHON) is the most commonly diagnosed mitochondrial disorder, resulting in colour vision abnormalities and rapid but painless deterioration of central vision. While numerous studies have assessed the impact of LHON on the quality of life (QoL) of LHON patients, the financial impact of the disease remains unexplored. This study attempts to calculate both the direct non-medical costs and the indirect costs associated with productivity losses experienced by people with LHON and their unpaid caregivers in Slovenia, in addition to assessing their QoL. Due to the rarity of the disease, the study involved a small sample size, which is important to note for interpreting the results.

METHODS

The analysis was conducted on nine adult participants diagnosed with LHON, representing one-third of the total number of known Slovenian patients with this condition. To thoroughly assess the economic and social impact of LHON, tailored questionnaires were designed to collect information on demographics, socioeconomic status, LHON severity, and associated non-medical and indirect costs.

RESULTS

The mean age of the study participants was 48.8 years (SD 13.3; n = 9). The annual productivity loss attributable to LHON, taking both absenteeism and relative presenteeism into account, was calculated to be EUR 11,608 per person affected. The mean VFQ-25 score, a measure of vision-related quality of life, for adult LHON patients was 30.4 (SD 12.9).

CONCLUSION

The findings highlight the significant economic and social burden of LHON on patients and their families. Ensuring prompt, accurate diagnosis, access to treatment, financial support, and psychological counselling and services are critical to helping individuals cope with and mitigate the profound challenges of vision loss and living with LHON.

摘要

简介

莱伯遗传性视神经病变(LHON)是最常见的诊断线粒体疾病,导致色觉异常和中央视力迅速但无痛恶化。虽然许多研究已经评估了 LHON 对 LHON 患者生活质量(QoL)的影响,但该疾病的经济影响仍未得到探索。本研究试图计算斯洛文尼亚 LHON 患者及其无偿照顾者的直接非医疗费用和与生产力损失相关的间接费用,此外还评估了他们的 QoL。由于该疾病的罕见性,该研究的样本量较小,这对于解释结果非常重要。

方法

该分析针对 9 名成年 LHON 患者进行,占已知患有这种疾病的斯洛文尼亚患者总数的三分之一。为了彻底评估 LHON 的经济和社会影响,专门设计了调查问卷,以收集人口统计学、社会经济状况、LHON 严重程度以及相关非医疗和间接费用信息。

结果

研究参与者的平均年龄为 48.8 岁(SD 13.3;n=9)。考虑到旷工和相对在职缺勤,归因于 LHON 的年生产力损失为每人 11608 欧元。成年 LHON 患者的平均 VFQ-25 评分(衡量与视力相关的生活质量的指标)为 30.4(SD 12.9)。

结论

这些发现强调了 LHON 对患者及其家庭的重大经济和社会负担。确保及时、准确的诊断、获得治疗、经济支持以及心理辅导和服务,对于帮助个人应对和减轻视力丧失和 LHON 生活的巨大挑战至关重要。

相似文献

1
Leber hereditary optic neuropathy in Slovenia: quality of life and costs from patient perspective.斯洛文尼亚的莱伯遗传性视神经病变:从患者角度看生活质量和成本。
Orphanet J Rare Dis. 2024 Aug 30;19(1):318. doi: 10.1186/s13023-024-03329-0.
2
Leber hereditary optic neuropathy in Czechia and Slovakia: Quality of life and costs from patient perspective.捷克和斯洛伐克的Leber遗传性视神经病变:从患者角度看生活质量和成本
Heliyon. 2024 May 31;10(11):e32296. doi: 10.1016/j.heliyon.2024.e32296. eCollection 2024 Jun 15.
3
Quality of life in patients with leber hereditary optic neuropathy.Leber遗传性视神经病变患者的生活质量
Invest Ophthalmol Vis Sci. 2009 Jul;50(7):3112-5. doi: 10.1167/iovs.08-3166. Epub 2009 Feb 28.
4
Smoking and alcohol, health-related quality of life and psychiatric comorbidities in Leber's Hereditary Optic Neuropathy mutation carriers: a prospective cohort study.Leber 遗传性视神经病变突变携带者中的吸烟和饮酒、健康相关生活质量和精神共病:一项前瞻性队列研究。
Orphanet J Rare Dis. 2021 Mar 11;16(1):127. doi: 10.1186/s13023-021-01724-5.
5
Demographics of a Large International Population of Patients Affected by Leber's Hereditary Optic Neuropathy.莱伯遗传性视神经病变大国际患者人群的人口统计学。
Ophthalmology. 2020 May;127(5):679-688. doi: 10.1016/j.ophtha.2019.11.014. Epub 2019 Nov 25.
6
Vitamin B12 in Leber hereditary optic neuropathy mutation carriers: a prospective cohort study.Leber 遗传性视神经病变突变携带者的维生素 B12:一项前瞻性队列研究。
Orphanet J Rare Dis. 2022 Aug 9;17(1):310. doi: 10.1186/s13023-022-02453-z.
7
The Impact of Leber Hereditary Optic Neuropathy on the Quality of Life of Patients and Their Relatives: A Qualitative Study.Leber 遗传性视神经病变对患者及其亲属生活质量的影响:一项定性研究。
J Neuroophthalmol. 2022 Sep 1;42(3):316-322. doi: 10.1097/WNO.0000000000001564. Epub 2022 Apr 27.
8
Establishing risk of vision loss in Leber hereditary optic neuropathy.建立莱伯遗传性视神经病变的致盲风险。
Am J Hum Genet. 2021 Nov 4;108(11):2159-2170. doi: 10.1016/j.ajhg.2021.09.015. Epub 2021 Oct 19.
9
Incidence of Leber hereditary optic neuropathy in 2019 in Japan: a second nationwide questionnaire survey.2019 年日本莱伯遗传性视神经病变的发病率:第二次全国问卷调查。
Orphanet J Rare Dis. 2022 Aug 20;17(1):319. doi: 10.1186/s13023-022-02478-4.
10
Nationwide epidemiological survey of Leber hereditary optic neuropathy in Japan.日本全国性的Leber遗传性视神经病变流行病学调查。
J Epidemiol. 2017 Sep;27(9):447-450. doi: 10.1016/j.je.2017.02.001. Epub 2017 Apr 6.

本文引用的文献

1
Leber's Hereditary Optic Neuropathy (LHON): Clinical Experience and Outcomes after Long-Term Idebenone Treatment.Leber遗传性视神经病变(LHON):长期艾地苯醌治疗后的临床经验与结果
Life (Basel). 2023 Sep 30;13(10):2000. doi: 10.3390/life13102000.
2
Case report: Long-term follow-up of two patients with LHON caused by DNAJC30:c.152G>A pathogenic variant-case series.病例报告:两例由DNAJC30:c.152G>A致病变异引起的Leber遗传性视神经病变患者的长期随访——病例系列
Front Neurol. 2022 Oct 28;13:1003046. doi: 10.3389/fneur.2022.1003046. eCollection 2022.
3
The national economic burden of rare disease in the United States in 2019.2019 年美国罕见病的国家经济负担。
Orphanet J Rare Dis. 2022 Apr 12;17(1):163. doi: 10.1186/s13023-022-02299-5.
4
The Impact of Inherited Retinal Diseases in the United States of America (US) and Canada from a Cost-of-Illness Perspective.从疾病成本角度看遗传性视网膜疾病在美国和加拿大的影响。
Clin Ophthalmol. 2021 Jul 1;15:2855-2866. doi: 10.2147/OPTH.S313719. eCollection 2021.
5
Leber Hereditary Optic Neuropathy: Review of Treatment and Management.Leber遗传性视神经病变:治疗与管理综述
Front Neurol. 2021 May 26;12:651639. doi: 10.3389/fneur.2021.651639. eCollection 2021.
6
Impaired complex I repair causes recessive Leber's hereditary optic neuropathy.复合物 I 修复缺陷导致常染色体隐性遗传视神经病变。
J Clin Invest. 2021 Mar 15;131(6). doi: 10.1172/JCI138267.
7
Real-World Clinical Experience With Idebenone in the Treatment of Leber Hereditary Optic Neuropathy.依地酸-beta-羟乙酯治疗莱伯遗传性视神经病变的真实世界临床经验。
J Neuroophthalmol. 2020 Dec;40(4):558-565. doi: 10.1097/WNO.0000000000001023.
8
The Impact of Inherited Retinal Diseases in the Republic of Ireland (ROI) and the United Kingdom (UK) from a Cost-of-Illness Perspective.从疾病成本角度看爱尔兰共和国(ROI)和英国(UK)遗传性视网膜疾病的影响。
Clin Ophthalmol. 2020 Mar 5;14:707-719. doi: 10.2147/OPTH.S241928. eCollection 2020.
9
Visual function in chronic Leber's hereditary optic neuropathy during idebenone treatment initiated 5 to 50 years after onset.发病后 5 至 50 年开始用艾地苯醌治疗莱伯遗传性视神经病变的慢性期的视觉功能。
Graefes Arch Clin Exp Ophthalmol. 2019 Dec;257(12):2751-2757. doi: 10.1007/s00417-019-04444-6. Epub 2019 Sep 3.
10
Evaluation of Vision-Related Quality of Life in Chinese Patients With Leber Hereditary Optic Neuropathy and the G11778A Mutation.中国莱伯遗传性视神经病变 G11778A 突变患者的视功能相关生活质量评估。
J Neuroophthalmol. 2019 Mar;39(1):56-59. doi: 10.1097/WNO.0000000000000644.